Unity Biotechnology Inc. (UBX) Dipped -5.6% or -0.45 To Price $7.59 On Monday


Unity Biotechnology Inc. (UBX) dipped -5.6% or -0.45 to $7.59. It is approximately 177547 shares traded, which is 89.52% compare to the average total volume 198337. The market cap of UBX is $325.28 million. The year to date change is -57.34%. The 52 week price range is from $7.39 to $24.56. Price of UBX have changed -5.19% during last week. It have changed -5.85% over last month, -48.53% over last 3 months, -33.88% over last 6 months and -51.71% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for UBX is 9.54. It is 25.69% above current price. The 200-day Moving Averages for UBX is 13.47. It is 77.47% above current price. The 52-week High is 24.56. It is 223.58% from the current price. The 52-week Low is 7.39. It is -2.64% from current price.

There are some statistics of UBX. It is has market cap $325.28 million. The share outstanding is 42.86 million. The average volume is 198337. The percent of top 15 Institution holding is 64.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of UBX is -196.95%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of UBX is -53.92%.


Tags:

Share this post